The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

By Michael Erman and Deena Beasley Jan 27 (Reuters) - The U.S. government on Tuesday named the 15 new drugs targeted for ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Medicare picks Botox and Trulicity for latest round of negotiations The Centers for ...

CMS will negotiate the prices for Trulicity, Biktarvy and 13 other high-cost medications commonly covered by Medicaid Parts B and D, according to a Jan. 27 news release from the agency.  The Medicare ...

A recent U.S. Court of Appeals for the Third Circuit ruling upholding the federal Inflation Reduction Act (IRA)’s drug price ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...

A new analysis from Vizient® shows that drug manufacturers are adjusting pricing strategies in markedly different ways ahead of upcoming Medicare Drug Price Negotiation Program (MDPNP) changes under ...